Frontlight ResearchEarly access
Trial site
Tsu
- 4running trials
- 3closed trials
The trials here
What the 7 trials at this site are about, from their registry records.
- Conditions
- Childhood cancers3 trials
- Acute lymphoblastic leukaemia1 trial
- Chronic myeloid leukaemia1 trial
- Diabetic eye disease1 trial
- Diffuse large B-cell lymphoma1 trial
- Familial hypercholesterolaemia1 trial
- Heart failure1 trial
- Lung cancer1 trial
- Myeloproliferative neoplasms1 trial
- Phase
- Phase 33 trials
- Status
- Completed3 trials
- Recruiting3 trials
- Active, not recruiting1 trial
- Lead sponsor
- Novartis Pharmaceuticals7 trials
Running trials
Recruiting
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
Recruiting
Active, not recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Acute lymphoblastic leukaemia1 recruiting
- Childhood cancers1 recruiting
- Diffuse large B-cell lymphoma1 recruiting
- Heart failure1 recruiting
- Myeloproliferative neoplasms1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 14 Nov 2026